CAS 1056164-52-3

1-(3-(tert-Butyl)-1-(3-chloro-4-hydroxyphenyl)-1H-pyrazol-5-yl)-3-(2-((3-(2-((2-hydroxyethyl)thio)phenyl)-[1,2,4]triazolo[4,3-a]pyridin-6-yl)thio)benzyl)urea

CAS : 1056164-52-3

1-(3-(tert-Butyl)-1-(3-chloro-4-hydroxyphenyl)-1H-pyrazol-5-yl)-3-(2-((3-(2-((2-hydroxyethyl)thio)phenyl)-[1,2,4]triazolo[4,3-a]pyridin-6-yl)thio)benzyl)urea

Degré de pureté : 98%

Masse moléculaire : 700.29g/mol

Ref: 54-OR1063038

1-(3-(tert-Butyl)-1-(3-chloro-4-hydroxyphenyl)-1H-pyrazol-5-yl)-3-(2-((3-(2-((2-hydroxyethyl)thio)phenyl)-[1,2,4]triazolo[4,3-a]pyri din-6-yl)thio)benzyl)urea

CAS : 1056164-52-3

1-(3-(tert-Butyl)-1-(3-chloro-4-hydroxyphenyl)-1H-pyrazol-5-yl)-3-(2-((3-(2-((2-hydroxyethyl)thio)phenyl)-[1,2,4]triazolo[4,3-a]pyri din-6-yl)thio)benzyl)urea is a research tool used to study the activation of receptor tyrosine kinases and ion channels. It is also used as an inhibitor for the inhibition of protein interactions. The CAS number for this compound is 1056164-52-3.

Formule : C₃₅H₃₄ClN₇O₃S₂

Degré de pureté : Min. 95%

Masse moléculaire : 700.3 g/mol

Ref: 3D-GSB16452

PF-03715455

CAS : 1056164-52-3

PF-03715455 is a potent p38 MAPK inhibitor, reducing TNFα in blood (IC50=1.7 nM) with selectivity for p38α, and may treat COPD.

Formule : C₃₅H₃₄ClN₇O₃S₂

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 700.27

Ref: TM-T16477